A 61603 hydrobromide - CAS 107756-30-9
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
Molecular Weight:
Adrenergic Receptor
A 61603 hydrobromide is a potent and selective α-adrenoceptor agonist with 35-fold selectivity for α1A over α1B or α1D sites. Activation of the α1A-adrenergic receptor by A 61603 induces dose response increases in spontaneous Ca2+ transients in rat ventricular myocytes in vitro (EC50 = 6.9 nmol/L).
Brife Description:
α1A-adrenergic receptor agonist
N-[5-(4,5-Dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl]methanesulfonamide hydrobromide
Canonical SMILES:
1.alpha1-Adrenoceptors in proximal segments of tail arteries from control and reserpinised rats.
Kamikihara SY;Mueller A;Lima V;Akinaga J;Nojimoto FD;Castilho A;Buratini J Jr;Pupo AS Naunyn Schmiedebergs Arch Pharmacol. 2007 Oct;376(1-2):117-26. Epub 2007 Aug 4.
It has been recently shown that the supersensitivity of distal segments of the rat tail artery to phenylephrine after chemical sympathectomy with reserpine results from the appearance of alpha(1D)-adrenoceptors. It is known that both alpha(1A)- and alpha(1D)-adrenoceptors are involved in the contractions of proximal portions of the rat tail artery. Therefore, this study investigated whether sympathectomy with reserpine would induce supersensitivity in proximal segments of the rat tail artery, a tissue in which alpha(1D)-adrenoceptors are already functional. Proximal segments of tail arteries from reserpinised rats were three- to sixfold more sensitive to phenylephrine and methoxamine than were arteries from control rats (n = 6-2; p < 0.05). The imidazolines N-[5-(4,5-Dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl]methanesulfonamide hydrobromide (A-61603) and oxymetazoline, which activate selectively alpha(1A)-adrenoceptors, were equipotent in tail arteries from control and reserpinised rats (n = 4-2; p < 0.05), whereas buspirone, which activates selectively alpha(1D)-adrenoceptor, was approximately 4-fold more potent in tail arteries from reserpinised rats (n = 4-6; p < 0.
2.A-61603, a potent alpha 1-adrenergic receptor agonist, selective for the alpha 1A receptor subtype.
Knepper SM;Buckner SA;Brune ME;DeBernardis JF;Meyer MD;Hancock AA J Pharmacol Exp Ther. 1995 Jul;274(1):97-103.
N-[5-(4,5-dihydro-1H-imidazol-2yl)-2-hydroxy-5,6,7,8-tetrahydro naphthalen-1-yl] methanesulfonamide hydrobromide (A-61603) is a novel and potent alpha-adrenoceptor agonist. In radioligand binding assays, the compound is at least 35-fold more potent at alpha 1A/a receptors than at alpha 1b or alpha 1d sites. In fibroblast cells transfected with alpha 1a receptors, A-61603 more potently stimulates phosphoinositide hydrolysis than norepinephrine, and is antagonized by prazosin. A-61603 is less potent in cells transfected with alpha 1b or alpha 1d receptors. A-61603 is a potent agonist at alpha 1A receptors in rat vas deferens (200- to 300-fold more potent than norepinephrine or phenylephrine, respectively) and in isolated canine prostate strips (130- to 165-fold more potent than norepinephrine or phenylephrine, respectively). In contrast, A-61603 is only 40-fold more potent than phenylephrine at alpha 1B sites in rat spleen and 35-fold less potent at rat aortic, alpha 1D sites. In an in vivo dog model, A-61603 raises intraurethral prostatic tone to a greater extent than mean arterial blood pressure. A-61603 induces a pressor response in conscious rats at doses 50- to 100-fold lower than phenylephrine, and the response is not attenuated by pretreatment with CEC, whereas YM-617 causes a 100-fold shift in the response.
3.Differential distribution of functional alph}1-adrenergic receptor subtypes along the rat tail artery.
Kamikihara SY;Mueller A;Lima V;Silva AR;da Costa IB;Buratini J Jr;Pupo AS J Pharmacol Exp Ther. 2005 Aug;314(2):753-61. Epub 2005 May 4.
The rat tail artery has been used for the study of vasoconstriction mediated by alpha(1A)-adrenoceptors (ARs). However, rings from proximal segments of the tail artery (within the initial 4 cm, PRTA) were at least 3-fold more sensitive to methoxamine and phenylephrine (n = 6-12; p < 0.05) than rings from distal parts (between the sixth and 10th cm, DRTA). Interestingly, the imidazolines N-[5-(4,5-dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl]methanesulfonamide hydrobromide (A-61603) and oxymetazoline, which activate selectively alpha(1A)-ARs, were equipotent in PRTA and DRTA (n = 4-12), whereas buspirone, which activates selectively alpha(1D)-AR, was approximately 70-fold more potent in PRTA than in DRTA (n = 8; p < 0.05). The selective alpha(1D)-AR antagonist 8-[2-[4-(methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride (BMY-7378) was approximately 70-fold more potent against the contractions induced by phenylephrine in PRTA (pK(B) of approximately 8.45; n = 6) than in DRTA (pK(B) of approximately 6.58; n = 6), although the antagonism was complex in PRTA. 5-Methylurapidil, a selective alpha(1A)-antagonist, was equipotent in PRTA and DRTA (pK(B) of approximately 8.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Adrenergic Receptor Products

CAS 41937-02-4 Brombuterol

(CAS: 41937-02-4)

Brombuterol is found to be a novel β-adrenergic agonist that can increase the meat-to-fat ratio but it is banned in animal feeds.

CAS 145108-58-3 Dexmedetomidine HCl

Dexmedetomidine HCl
(CAS: 145108-58-3)

Dexmedetomidine HCl is a highly selective and potent alpha-2 adrenoceptor agonist, which reduces anesthetic requirements for patients by providing significant s...

CAS 34391-04-3 Levalbuterol

(CAS: 34391-04-3)

Levalbuterol is a short-acting beta 2 adrenergic agonist. Levalbuterol binds to beta 2 adrenergic receptors and activates intracellular adenyl cyclase to promot...

CAS 181217-39-0 Fenoldopam hydrochloride

Fenoldopam hydrochloride
(CAS: 181217-39-0)

Fenoldopam hydrochloride is a selective partial agonist of dopamine D1 receptor (EC50 = 57 nM). It also acts as an α2-adrenoceptor antagonist in vitro (Ki = 15 ...

CAS 90845-56-0 Trecadrine

(CAS: 90845-56-0)

Trecadrine, a new β3-adrenergic agonist, decreases fat content and increases gastrocnemius muscle UCP2 gene expression in a diet-induced obesity model.

CAS 118457-15-1 (+)-Nebivolol

(CAS: 118457-15-1)

This active molecular is a β-adrenergic receptor antagonist. Dexnebivolol is an enantiomer of Nebivolol which is a β1 receptor blocker with nitric oxide-potenti...

(CAS: 185739-21-3)

GYKI-16084 is a postsynaptic alpha2-blocker with the potential to treat benign prostatic hyperplasia.

CAS 22664-55-7 Metipranolol

(CAS: 22664-55-7)

Metipranolol is a non-selective beta blocker used in eye drops to treat glaucoma.

Chemical Structure

CAS 107756-30-9 A 61603 hydrobromide

Quick Inquiry

Verification code

Featured Items